Novo Nordisk invests over USD 740m in Danish facility

The pharmaceutical firm is expanding its production facilities in Bagsværd, a Copenhagen suburb.

Photo: Stine Tidsvilde

Novo Nordisk plans to invest DKK 5.4bn (USD 744.4m) on expanding its existing facilities in Bagsværd, Greater Copenhagen, and construct a new building in extension of the existing site, the company writes in a press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs